Interleukin-12 Antagonist [EPC] - N0000192797
Pharmacologic Class Information
Pharmacologic Code | N0000192797 |
Pharmacologic Name | Interleukin-12 Antagonist |
Pharmacologic Uses |
|
Pharmacologic Concept | Established Pharmacologic Classes - [EPC] |
Pharmacologic Concept Description | An established pharmacologic class is a term or phrase that is scientifically valid
and clinically meaningful according to the following definitions:
|
NDC Products with Interleukin-12 Antagonist
The table contains 3 products whose active ingredient are classified under the same pharmacologic class Interleukin-12 Antagonist [EPC].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
57894-054 | Stelara | Non-Proprietary Name: Ustekinumab | Solution | Intravenous | Janssen Biotech, Inc. | ACTIVE | |
57894-060 | Stelara | Non-Proprietary Name: Ustekinumab | Injection, Solution | Subcutaneous | Janssen Biotech, Inc. | ACTIVE | |
57894-061 | Stelara | Non-Proprietary Name: Ustekinumab | Injection, Solution | Subcutaneous | Janssen Biotech, Inc. | ACTIVE |